טוען...
Transbronchial biopsies safely diagnose amyloid lung disease
BACKGROUND: Autopsy identifies lung involvement in 58–92% of patients with the most prevalent forms of systemic amyloidoses. In the absence of lung biopsies, amyloid lung disease often goes unrecognized. Report of a death following transbronchial biopsies in a patient with systemic amyloidosis cauti...
שמור ב:
| הוצא לאור ב: | Amyloid |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6014610/ https://ncbi.nlm.nih.gov/pubmed/28393574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2017.1301917 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|